Logo

AlphaGenics Renews Pathway License from Ariadne

Feb 14, 2006

NEW YORK, Feb. 14 (GenomeWeb News) -

 Ariadne announced today that AlphaGenics has licensed its PathwayStudio 4.0 software for use its nutrigenomic studies.

 

AlphaGenics, a Rockville, Md.-based developer of personalized consumer lifestyle and vanity products, has been using an earlier version of the software, Ariadne said.

 

Pathway Studio 4.0 comes with the ResNet database of 700,000 functional relationships and over 1,000 newly reconstructed pathways, and with the MedScan Reader biomedical literature browser.

 

Financial deals were not released.

Breaking News
The Scan

Boosters Chasing Variants

The New York Times reports that an FDA advisory panel is to weigh updated booster vaccines for COVID-19.

Not Yet

The World Health Organization says monkeypox is not yet a global emergency, the Washington Post reports.

More Proposed for Federal Research

Science reports that US House of Representatives panels are seeking to increase federal research funding.

PLOS Papers on Breast Cancer Metastasis, Left-Sided Cardiac Defects, SARS-CoV-2 Monitoring

In PLOS this week: link between breast cancer metastasis and CLIC4, sequencing analysis of left-sided cardiac defects, and more.